沃格光电:在生物医药领域,公司重点推进微流控生物芯片的研发与产业化

Core Viewpoint - The company is advancing the research and industrialization of microfluidic biochips in the biomedicine sector, leveraging its leading capabilities in glass-based precision processing [2]. Group 1 - The company has completed customer sample verification for its microfluidic biochip products [2]. - The products are about to enter the mass production and shipping phase [2].

WG Tech-沃格光电:在生物医药领域,公司重点推进微流控生物芯片的研发与产业化 - Reportify